Drug Changes

Here you will find a listing of the drugs that have been changed on our drug list (formulary) for the plan year you select.


Buphenyl TABLET 500 MG Oral


Post Date:
5/15/2018
Effective Date:
5/15/2018
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available

Methadose CONCENTRATE 10 MG/ML ORAL


Post Date:
6/15/2018
Effective Date:
6/15/2018
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available

Methadose Sugar-Free CONCENTRATE 10 MG/ML ORAL


Post Date:
6/15/2018
Effective Date:
6/15/2018
Type of Change:
Drug removed
Reason Changed:
Generic therapeutically equivalent product available

Signifor SOLUTION 0.3 MG/ML Subcutaneous


Post Date:
7/15/2018
Effective Date:
7/15/2018
Type of Change:
Cost sharing change
Reason Changed:
SP drug

Signifor SOLUTION 0.6 MG/ML Subcutaneous


Post Date:
7/15/2018
Effective Date:
7/15/2018
Type of Change:
Cost sharing change
Reason Changed:
SP drug

Signifor SOLUTION 0.9 MG/ML Subcutaneous


Post Date:
7/15/2018
Effective Date:
7/15/2018
Type of Change:
Cost sharing change
Reason Changed:
SP drug

Cayston SOLUTION RECONSTITUTED 75 MG INHALATION


Post Date:
7/15/2018
Effective Date:
7/15/2018
Type of Change:
Invalid Negative Change
Reason Changed:
New therapy class per FN

Acidophilus TABLET CHEWABLE ORAL


Post Date:
7/15/2018
Effective Date:
7/15/2018
Type of Change:
Invalid Negative Change
Reason Changed:
New therapy class per FN

Aztreonam SOLUTION RECONSTITUTED 1 GM INJECTION


Post Date:
7/15/2018
Effective Date:
7/15/2018
Type of Change:
Invalid Negative Change
Reason Changed:
New therapy class per FN

Aztreonam SOLUTION RECONSTITUTED 2 GM INJECTION


Post Date:
7/15/2018
Effective Date:
7/15/2018
Type of Change:
Invalid Negative Change
Reason Changed:
New therapy class per FN